The application of transgenic mice for therapeutic antibody discovery.

In 2006, panitumumab, the first fully human antibody generated from transgenic mice, was approved for clinical use by the US Food and Drug Administration (FDA). Since then, a further seven such antibodies have been approved. In this chapter, we discuss how transgenic mice technologies can provide a powerful platform for creating human therapeutic antibodies.

Citation

E-Chiang Lee, Michael Owen. The application of transgenic mice for therapeutic antibody discovery. Methods in molecular biology (Clifton, N.J.). 2012;901:137-48

Mesh Tags

Substances

PMID: 22723098

search → result